RNS Number : 1696M
Spirax Group PLC
18 December 2025
 

 

18 December 2025

Spirax Group PLC

("Spirax" or "the Group")

 

Correction: Block Listing Application

 

The admission date stated in the announcement published on 18 December 2025 under RNS Number 1312M was incorrect. The correct admission date is 19 December 2025.

 

Spirax announces that an application has been made to the London Stock Exchange for the block admission of a total of 200,000 Ordinary Shares of 2612/13p each in the capital of the Group (the "Ordinary Shares") to be admitted to trading on the Main Market.

 

The shares will be issued, from time to time, to the Spirax Group plc's Employee Benefit Trust in connection with the following schemes:

 

·     Spirax Group plc Performance Share Plan

·     Spirax Group plc Employee Share Ownership Plan          

Upon exercise, the Ordinary Shares will be issued credited as fully paid and will rank pari passu in all respects with the Group's existing Ordinary Shares in issue.

 

It is expected that admission will become effective on 19 December 2025.

 

 

For further information:

Celine Barroche, Group Company Secretary       +44 (0) 1242 535 276

 

Spirax Group is positioned to play a critical role in enabling the industrial transition to net zero, aligned to our Purpose to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world.  We put solving customers' problems at the heart of our total solutions approach.  Our global thermal energy and fluid technology solutions improve operating efficiency and safety in our customers' critical industrial processes.  Our new-to-world decarbonisation* solutions will use our proprietary technologies to electrify boilers, for the raising of steam, as well as the electrification of other critical industrial process heating applications.

Spirax Group comprises three strong and aligned Businesses: Steam Thermal Solutions helps customers control and manage steam within their mission critical industrial applications, such as cleaning, sterilising, cooking and heating.  We are helping to put food safely on the world's tables and keeping our hospitals running. Electric Thermal Solutions has proprietary technologies that deliver electrification solutions at scale in industrial settings, including for the raising of steam, supporting our customers to achieve their net zero goals. We also deliver freeze protection and defrost solutions critical to aviation and space industries and ensure thermal uniformity in Semiconductor chip manufacturing to power the critical electronic systems we rely on.  WatsonMarlow Fluid Technology Solutions is engineering vital fluid technology solutions that optimise the efficient use of resources and support advancements in global health, such as lifesaving vaccines and gene therapies.

Spirax Group is headquartered in Cheltenham (UK). We have over 30 strategically located manufacturing plants around the world and are committed to creating a safe and inclusive working culture for our 10,000 colleagues, operating in nearly 70 countries and serving over 100,000 customers globally. 

The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good Indexes.

 

* Eliminates Scopes 1 and 2 greenhouse gas emissions when connected to a green electricity source.

 

Further information can be found at spiraxgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFFFFLAEISEFE